Aduro Biotech Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
BERKELEY, Calif., May 02, 2018 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the first quarter ended March 31, 2018. Net loss for the first quarter of 2018 was $21.5 million, or $0.28 per...
Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 02, 2018 20:01 pm UTC| Business
The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3The 20ug dose of G100 shows a two-fold increase in TILs, higher than that seen at the 10ug doseConference call at 1:30 pm Pacific today SEATTLE...
Cerner Reports First Quarter 2018 Results
May 02, 2018 20:01 pm UTC| Business
KANSAS CITY, Mo., May 02, 2018 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2018 first quarter that ended March 31, 2018. Bookings in the first quarter of 2018 were $1.398 billion, an increase...
Harvard Bioscience Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
-Reports GAAP and adjusted non-GAAP revenue of $26.8 million and $27.7 million, respectively, an increase of 48% and 15%, respectively- HOLLISTON, Mass., May 02, 2018 -- Harvard Bioscience, Inc. (Nasdaq:HBIO), or the...
Trevena to Present at the Deutsche Bank 43rd Annual Healthcare Conference
May 02, 2018 20:01 pm UTC| Business
CHESTERBROOK, Pa., May 02, 2018 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Deutsche Bank 43rd Annual Healthcare Conference on Tuesday, May 8th, 2018, at 3:30 p.m. EDT in Boston,...
3D Systems Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
ROCK HILL, S.C., May 02, 2018 -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2018. For the first quarter of 2018, the company reported six percent...
Nuvectra™ Reports First Quarter 2018 Financial Results
May 02, 2018 20:01 pm UTC| Business
PLANO, Texas, May 02, 2018 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2018. Highlights Reported...